<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03834168</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-300002114</org_study_id>
    <nct_id>NCT03834168</nct_id>
  </id_info>
  <brief_title>The Diurnal Rhythm in Natriuretic Peptide Levels</brief_title>
  <official_title>The Diurnal Rhythm in Natriuretic Peptide Levels and Relationship With Nocturnal Blood Pressure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study to assess the diurnal rhythm in natriuretic peptide levels and its
      temporal relationship with nocturnal blood pressure in obese and African-American individuals
      as compared with lean and white individuals.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obese and African-American individuals are at greater risk for cardiovascular morbidity and
      mortality than lean and white individuals. One of the key reasons for this health disparity
      is a higher risk of hypertension among obese and African-American individuals. The reasons
      for why these disparities develop are not well understood.

      Natriuretic peptides are hormones produced by the heart and have a wide range of favorable
      cardiovascular effects such as natriuresis (sodium excretion), vasodilation, and direct
      inhibition of the renin-angiotensin-aldosterone system. Human studies showed the existence of
      24-hour (diurnal) variations in the circulating natriuretic peptide levels.

      Prior work from the investigators and others demonstrated that individuals with
      genetically-determined lower circulating natriuretic peptides levels have higher blood
      pressure and greater risk of hypertension. Further, the investigators have shown that obesity
      and African-American race are associated with lower natriuretic peptide levels, suggesting
      that relatively low natriuretic peptide levels may be a biologic determinant contributing to
      health disparities.

      Obese and African-American individuals have a greater prevalence of nocturnal hypertension
      [nighttime blood pressure &gt;120/80 mmHg], which is an independent risk factor for
      cardiovascular events. The underlying reasons for 24-hour variations in blood pressure are
      unknown.

      The investigators hypothesize that loss of the natural 24-hour rhythm of natriuretic peptide
      levels plays a role in the development of nocturnal hypertension in obese and
      African-American individuals. The aims of this study are:

        1. to examine whether there is a presence of a 24-hour rhythm in natriuretic peptide levels
           among normotensive obese and African-American individuals and whether there is a
           difference in the rhythmicity of natriuretic peptide levels between obese and lean as
           well as in African-Americans and whites;

        2. to examine whether there is an existence of a relationship between 24-hour variability
           of natriuretic peptide levels and 24-hour patterns of blood pressure and whether this
           relationship of rhythmicity of natriuretic peptide levels and nocturnal blood pressure
           differed in obese and lean individuals and by race.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Anticipated">May 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma MRproANP</measure>
    <time_frame>About 24 hours on the in-patient study visit day after consuming study meals for 5 days</time_frame>
    <description>Assess the diurnal rhythm in circulating MRproANP levels among obese individuals and compared it with lean individuals</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma MRproANP</measure>
    <time_frame>About 24 hours on the in-patient study visit day after consuming study meals for 5 days</time_frame>
    <description>Assess the diurnal rhythm in circulating MRproANP levels among African-American individuals and compared it with white individuals</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nocturnal Blood Pressure</measure>
    <time_frame>About 24 hours on the in-patient study visit day after consuming study meals for 5 days</time_frame>
    <description>Assess relationship between 24-hour variability of MRproANP levels and 24-hour patterns of blood pressure and whether this relationship of rhythmicity of MRproANP levels and nocturnal blood pressure differed in obese and lean individuals and by race</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Natriuretic Peptides</condition>
  <condition>Obesity</condition>
  <condition>Nocturnal Blood Pressure</condition>
  <arm_group>
    <arm_group_label>Study Individuals</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Healthy self-identified African-American and white male participants will be screened. Study consent will be obtained, medical history and physical examination administered, and study eligibility determined based on the inclusion and exclusion criteria. Eligible subjects will meet a bio-nutritionist who will explain the 5 days of standardized diet at the screening visit and will review instructions for complying with the diet. If the subject agrees to adhere to the study diet, they will then be enrolled in the study (stratified by race).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>standardized Study Diet</intervention_name>
    <description>Standardized diet consisted with eucaloric meals with 4.5 gm of sodium per day for 5 days.</description>
    <arm_group_label>Study Individuals</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 to 40 years

          -  Blood pressure less than 140/90

          -  Body Mass Index between 18.5 to 25 kg/m2 (lean) or 30 to 45 kg/m2 (obese)

          -  Self identified African-American or white individuals

          -  Willingness to comply with the study diet

          -  Provide informed consent

        Exclusion Criteria:

          -  History of hypertension

          -  History of cardiovascular, renal, or liver disease

          -  Diabetes or use of glucose-lowering medications

          -  Use of vasoactive or diuretic medications

          -  Atrial fibrillation

          -  Anemia (Hematocrit &lt;41%)

          -  Abnormal serum sodium or potassium

          -  Abnormal liver function tests (&gt;3x upper limit of normal)

          -  Current smokers

          -  Regular users of non-steroid anti-inflammatory medications
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pankaj Arora, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Orlando M Gutierrez, MMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pankaj Arora, MD</last_name>
    <phone>205-996-6630</phone>
    <email>parora@uabmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nirav Patel, MD</last_name>
    <phone>205-934-6058</phone>
    <email>npatel@uabmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deborah Weber, BSN, RN</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Goetze JP, Jørgensen HL, Sennels HP, Fahrenkrug J. Diurnal plasma concentrations of natriuretic propeptides in healthy young males. Clin Chem. 2012 Apr;58(4):789-92. doi: 10.1373/clinchem.2011.178921. Epub 2012 Jan 26.</citation>
    <PMID>22282468</PMID>
  </results_reference>
  <results_reference>
    <citation>Arora P, Reingold J, Baggish A, Guanaga DP, Wu C, Ghorbani A, Song Y, Chen-Tournaux A, Khan AM, Tainsh LT, Buys ES, Williams JS, Heublein DM, Burnett JC, Semigran MJ, Bloch KD, Scherrer-Crosbie M, Newton-Cheh C, Kaplan LM, Wang TJ. Weight loss, saline loading, and the natriuretic peptide system. J Am Heart Assoc. 2015 Jan 16;4(1):e001265. doi: 10.1161/JAHA.114.001265.</citation>
    <PMID>25595796</PMID>
  </results_reference>
  <results_reference>
    <citation>Bajaj NS, Gutiérrez OM, Arora G, Judd SE, Patel N, Bennett A, Prabhu SD, Howard G, Howard VJ, Cushman M, Arora P. Racial Differences in Plasma Levels of N-Terminal Pro-B-Type Natriuretic Peptide and Outcomes: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. JAMA Cardiol. 2018 Jan 1;3(1):11-17. doi: 10.1001/jamacardio.2017.4207.</citation>
    <PMID>29167879</PMID>
  </results_reference>
  <results_reference>
    <citation>Arora P, Wu C, Hamid T, Arora G, Agha O, Allen K, Tainsh RET, Hu D, Ryan RA, Domian IJ, Buys ES, Bloch DB, Prabhu SD, Bloch KD, Newton-Cheh C, Wang TJ. Acute Metabolic Influences on the Natriuretic Peptide System in Humans. J Am Coll Cardiol. 2016 Feb 23;67(7):804-812. doi: 10.1016/j.jacc.2015.11.049.</citation>
    <PMID>26892417</PMID>
  </results_reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>February 6, 2019</study_first_submitted>
  <study_first_submitted_qc>February 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 7, 2019</study_first_posted>
  <last_update_submitted>April 24, 2020</last_update_submitted>
  <last_update_submitted_qc>April 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Pankaj Arora, MD</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Diurnal Rhythm</keyword>
  <keyword>Race</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

